We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

Hormones · Menopause

DHEA in menopause: what it does and doesn't do

DHEA is a precursor hormone that declines with age. Intravaginal DHEA (prasterone, Intrarosa) is FDA-approved for genitourinary syndrome. Oral DHEA supplementation is more controversial — modest benefit for mood and libido in some women, no benefit in others.

Written by the Kindr Health Editorial & Clinical TeamMedically reviewed by Kindr Health Clinical Team NPI 1609792902Published Last reviewed

Reasonable uses

  • Vaginal prasterone 6.5mg for GSM
  • Low-dose oral DHEA 10–25mg with documented low DHEA-S and symptoms
  • Not for general anti-aging

Frequently asked questions

Should everyone take DHEA?

No. Targeted use for GSM (vaginal) or measured low DHEA-S with symptoms is reasonable.

Is DHEA safe?

Vaginal prasterone: yes. Oral DHEA at high doses: can cause acne, hair growth, mood shifts.

Does DHEA raise estrogen?

It converts to both estrogens and androgens peripherally; results vary by individual.

Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.

Request your Longevity Consult →

Explore Kindr Health

HRT Hub →
Estrogen, progesterone, testosterone protocols
34 Symptoms →
The complete symptom index
Care Near Me →
Find menopause care in your city
Browse by State →
Licensed clinicians in all 50 states
Kindr Journal →
Evidence-based menopause reporting
Editorial Team →
Who reviews Kindr clinical content

Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service

Written and medically reviewed by the Kindr Health Clinical Team · Published 2026-06-19 · Last reviewed 2026-07-01. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.